## Analysis of Rh Blood Group System Statements ### Correct Statements (Options A, C, D) **Option A — Rh-Negative Sensitization** **Key Point:** Rh-negative individuals do NOT naturally possess anti-D antibodies (unlike ABO antibodies, which are naturally occurring/isohemagglutinins). Anti-D antibodies develop only after exposure to Rh-positive RBCs through transfusion or fetomaternal hemorrhage (FMH). This is a fundamental distinction between the Rh and ABO systems. **Option C — D Antigen Immunogenicity** **Key Point:** The D antigen is indeed the most immunogenic of all Rh antigens. A single exposure of an Rh-negative individual to Rh-positive blood has approximately a 50–70% chance of inducing anti-D antibody formation. Among Rh antigens (D, C, c, E, e), D is by far the most clinically significant. Rh incompatibility (anti-D) is responsible for the majority of hemolytic transfusion reactions caused by Rh system antibodies, and is the leading cause of hemolytic disease of the fetus and newborn (HDFN). [Ganong's Review of Medical Physiology; Hoffbrand's Essential Haematology] **Option D — Anti-D Prophylaxis in Pregnancy** **Key Point:** An Rh-negative mother carrying an Rh-positive fetus requires anti-D immunoglobulin (300 μg / 1500 IU in the US; 500 IU in the UK) administered intramuscularly within **72 hours of delivery** to prevent sensitization and alloimmunization. Failure to administer anti-D prophylaxis can lead to Rh alloimmunization, causing hemolytic disease of the newborn (HDN) in subsequent pregnancies. **Clinical Pearl:** Anti-D immunoglobulin works by clearing fetal Rh-positive RBCs from the maternal circulation before the mother's immune system can mount a primary response. --- ### Incorrect Statement (Option B) — The Answer **High-Yield:** The statement that "Rh-negative blood can be safely transfused to **both** Rh-positive and Rh-negative recipients **without any risk** of hemolytic reaction" is FALSE. - Transfusing Rh-negative blood to an **Rh-positive recipient** is safe and carries no hemolytic risk (the recipient lacks anti-D antibodies against Rh-negative cells). - However, transfusing Rh-negative blood to an **Rh-negative recipient** is NOT without risk in all scenarios. If an Rh-negative recipient has been previously sensitized (e.g., by prior transfusion or pregnancy) and has developed anti-D antibodies, transfusing Rh-negative blood is safe. But the critical issue is that Rh-negative blood should ideally be reserved for Rh-negative recipients to prevent alloimmunization — it is not universally "safe without any risk." - More importantly, the phrase "without **any** risk of hemolytic reaction" is categorically false: Rh-negative blood can still cause hemolytic reactions due to **other blood group incompatibilities** (e.g., ABO, Kell, Duffy, Kidd systems). Compatibility is not determined by Rh status alone. - Additionally, O-negative blood (the "universal donor") is only a practical emergency measure; full cross-matching is always preferred. **Warning:** This is a classic distractor. Rh-negative blood is NOT universally safe for all recipients under all circumstances. The absolute statement "without any risk" makes Option B false. ### Summary Table | Statement | True/False | |---|---| | A: Anti-D is not naturally occurring; develops after sensitization | TRUE | | B: Rh-negative blood safe for ALL recipients without ANY risk | FALSE ✓ (Answer) | | C: D antigen is most immunogenic Rh antigen | TRUE | | D: Anti-D Ig within 72 hours post-delivery for Rh-negative mothers | TRUE | [cite: Ganong's Review of Medical Physiology 26e; Hoffbrand's Essential Haematology 7e; AABB Technical Manual 20e]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.